Chemed (NYSE:CHE) EVP Spencer Lee Sells 1,000 Shares of Stock

Chemed Corporation (NYSE:CHE) EVP Spencer Lee sold 1,000 shares of Chemed stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the completion of the sale, the executive vice president directly owned 13,912 shares of the company’s stock, valued at approximately $7,526,948.48. This trade represents a 6.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Chemed Stock Performance

Shares of CHE stock traded up $0.95 during mid-day trading on Monday, reaching $541.52. 21,011 shares of the company’s stock traded hands, compared to its average volume of 215,475. The firm has a 50 day moving average price of $499.24 and a two-hundred day moving average price of $446.50. The firm has a market capitalization of $7.08 billion, a PE ratio of 27.21, a price-to-earnings-growth ratio of 2.05 and a beta of 0.51. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $557.00. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. Chemed’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period last year, the company posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, research analysts forecast that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be issued a $0.70 dividend. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Monday, August 17th. This is a positive change from Chemed’s previous quarterly dividend of $0.60. Chemed’s dividend payout ratio (DPR) is currently 14.06%.

Wall Street Analyst Weigh In

CHE has been the subject of several recent analyst reports. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Oppenheimer boosted their price objective on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday, July 31st. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Royal Bank Of Canada increased their price target on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $530.75.

Institutional Investors Weigh In On Chemed

A number of hedge funds have recently bought and sold shares of the company. Geneos Wealth Management Inc. raised its stake in shares of Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Chemed by 67.0% during the second quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock valued at $5,534,000 after acquiring an additional 4,560 shares during the period. Marshall Wace LLP acquired a new stake in shares of Chemed in the 2nd quarter valued at $579,000. Brown Advisory Inc. boosted its stake in shares of Chemed by 36.9% in the 2nd quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock valued at $267,000 after purchasing an additional 148 shares in the last quarter. Finally, Cerity Partners LLC grew its holdings in shares of Chemed by 237.7% in the 2nd quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock worth $2,165,000 after purchasing an additional 3,133 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.